Search

Author/Creator Higasa, S.

1. A Phase II clinical trial of a mixture of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics. (6th June 2013)

Authors:
Shirahata, A.; Fukutake, K.; Takamatsu, J.; Shima, M.; Hanabusa, H.; Mugishima, H.; Amano, K.; Takedani, H.; Tamashima, S.; Matsushita, T.; Tawa, A.; Tanaka, I.; Higasa, S.; Kosaka, Y.; Fujii, T.; Sakai, M.; Migita, M.; Kawakami, K.; Ohashi, Y.; Saito, H.
Journal:
Haemophilia
Issue:
Volume 19:Number 6(2013:Nov.)
Page Start:
853
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase III clinical trial of a mixture agent of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors. Issue 1 (1st August 2016)

Authors:
Shinkoda, Y.; Shirahata, A.; Fukutake, K.; Takamatsu, J.; Shima, M.; Hanabusa, H.; Mugishima, H.; Takedani, H.; Kawasugi, K.; Taki, M.; Matsushita, T.; Tawa, A.; Nogami, K.; Higasa, S.; Kosaka, Y.; Fujii, T.; Sakai, M.; Migita, M.; Uchiba, M.; Kawakami, K.
Journal:
Haemophilia
Issue:
Volume 23:Issue 1(2017)
Page Start:
59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Results of clot waveform analysis and thrombin generation test for a plasma‐derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors—phase I trial: 2nd report. (19th September 2012)

Authors:
Shirahata, A.; Fukutake, K.; Mimaya, J.; Takamatsu, J.; Shima, M.; Hanabusa, H.; Takedani, H.; Takashima, Y.; Matsushita, T.; Tawa, A.; Higasa, S.; Takata, N.; Sakai, M.; Kawakami, K.; Ohashi, Y.; Saito, H.
Journal:
Haemophilia
Issue:
Volume 19:Number 2(2013:Mar.)
Page Start:
330
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗